Live Cases from Los Robles Regional Medical Center | Los Angeles, CA

Sunday, March 9, 2025

4:45 PM - 5:30 PM ET

Live Case Operator(s)

Saibal Kar, MD, FSCAI, FACC

Director of Structural Heart Disease, Interventions and Research Physician Director, Interventional Cardiology, HCA Healthcare
HCA-Los Robles Regional Medical Center, Thousand Oaks, CA
Thousand Oaks, California, United States

No relationships to disclose

Moderator(s)

Ramon Quesada, MD, FACP, FACC, FSCAI

Medical Director of Interventional Cardiology, Structural Heart & Cardiac Research
Miami Cardiac & Vascular Institute
Miami, Florida, United States

No relationships to disclose

Panel Discussant(s)

Anita W. Asgar, MD, FACC, FSCAI

Interventional Cardiologist
Northwestern Medicine
Chicago, Illinois, United States

No relationships to disclose
Chetan Huded, MD, MSc

Associate Medical Director, Structural Intervention
Saint Luke's Mid America Heart Institute
Kansas City, Missouri, United States

No relationships to disclose
Homam Ibrahim, MD

Medical Director- Structural Heart Clinic
Adventist HealthCare White Oak Medical Center
Silver Spring, Maryland, United States

No relationships to disclose
Paul Sorajja, MD

Director, Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital
Allina Health Minneapolis Heart Institute
Minneapolis, Minnesota, United States

No relationships to disclose
Anene Ukaigwe, MD

Interventional and Structural Cardiologist
University Hospitals, Cleveland Medical Center
PepperPike, Ohio, United States

Disclosure information not submitted.

Disclosure(s):

Saibal Kar, MD, FSCAI, FACC: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Pi-Cardia: Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Ramon Quesada, MD, FACP, FACC, FSCAI: Abbott Labs: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Chetan Huded, MD, MSc: Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Terminated)

Homam Ibrahim, MD: Edward Lifesciences: Stock-publicly held company (excluding mutual/index funds) (Ongoing); Medtronic, Boston Scientific, V wave, LAMINAR: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Paul Sorajja, MD: LAZA: Consulting Fees (e.g., advisory boards) (Ongoing)

Anene Ukaigwe, MD: Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing)